Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 334

1.

Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China.

Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, Tan X, Wang L, Mao Q, Wu J, Hu Y, Ji T, Song L, Liang Q, Zhang B, Gao Q, Li J, Wang S, Hu Y, Gu S, Zhang J, Yao G, Gu J, Wang X, Zhou Y, Chen C, Zhang M, Cao M, Wang J, Wang H, Wang N.

N Engl J Med. 2014 Feb 27;370(9):818-28. doi: 10.1056/NEJMoa1304923.

PMID:
24571754
[PubMed - indexed for MEDLINE]
2.

Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia.

McManus M, Frangoul H, McCullers JA, Wang L, O'Shea A, Halasa N.

Pediatr Blood Cancer. 2014 May;61(5):815-20. doi: 10.1002/pbc.24863. Epub 2013 Nov 19.

PMID:
24249544
[PubMed - indexed for MEDLINE]
3.

Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults.

Verdijk P, Rots NY, van Oijen MG, Oberste MS, Boog CJ, Okayasu H, Sutter RW, Bakker WA.

Vaccine. 2013 Nov 12;31(47):5531-6. doi: 10.1016/j.vaccine.2013.09.021. Epub 2013 Sep 21.

PMID:
24063976
[PubMed - indexed for MEDLINE]
4.

Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18-64 years of age.

Gorse GJ, Falsey AR, Johnson CM, Morrison D, Fried DL, Ervin JE, Greenberg DP, Ozol-Godfrey A, Landolfi V, Tsang PH.

Vaccine. 2013 Dec 5;31(50):6034-40. doi: 10.1016/j.vaccine.2013.09.012. Epub 2013 Sep 20.

PMID:
24055306
[PubMed - indexed for MEDLINE]
5.

A pilot randomized study to assess immunogenicity, reactogenicity, safety and tolerability of two human papillomavirus vaccines administered intramuscularly and intradermally to females aged 18-26 years.

Nelson EA, Lam HS, Choi KC, Ho WC, Fung LW, Cheng FW, Sung RY, Royals M, Chan PK.

Vaccine. 2013 Jul 25;31(34):3452-60. doi: 10.1016/j.vaccine.2013.06.034. Epub 2013 Jun 12.

PMID:
23770335
[PubMed - indexed for MEDLINE]
6.

The safety and immunogenicity of trivalent inactivated influenza vaccination: a study of maternal-cord blood pairs in Taiwan.

Lin SY, Wu ET, Lin CH, Shyu MK, Lee CN.

PLoS One. 2013 Jun 6;8(6):e62983. doi: 10.1371/journal.pone.0062983. Print 2013.

PMID:
23762229
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Pharmacokinetic modeling as an approach to assessing the safety of residual formaldehyde in infant vaccines.

Mitkus RJ, Hess MA, Schwartz SL.

Vaccine. 2013 Jun 7;31(25):2738-43. doi: 10.1016/j.vaccine.2013.03.071. Epub 2013 Apr 11.

PMID:
23583892
[PubMed - indexed for MEDLINE]
8.

Safety and immunogenicity of a new purified vero cell rabies vaccine (PVRV) administered by intramuscular and intradermal routes in healthy volunteers.

Kulkarni PS, Sapru A, D'costa PM, Pandit A, Madhusudana SN, Yajaman AB, Mangrule S, Gunale B, Bavdekar AR.

Vaccine. 2013 May 31;31(24):2719-22. doi: 10.1016/j.vaccine.2013.03.050. Epub 2013 Apr 12.

PMID:
23583817
[PubMed - indexed for MEDLINE]
9.

DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial.

Graham BS, Enama ME, Nason MC, Gordon IJ, Peel SA, Ledgerwood JE, Plummer SA, Mascola JR, Bailer RT, Roederer M, Koup RA, Nabel GJ; VRC 008 Study Team.

PLoS One. 2013;8(4):e59340. doi: 10.1371/journal.pone.0059340. Epub 2013 Apr 8.

PMID:
23577062
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Randomized trial using ultrasound to assess intramuscular vaccination at a 60° or 90° needle angle.

Marshall HS, Clarke MF, Evans S, Piotto L, Gent RJ.

Vaccine. 2013 May 28;31(23):2647-52. doi: 10.1016/j.vaccine.2013.03.037. Epub 2013 Apr 6.

PMID:
23566948
[PubMed - indexed for MEDLINE]
11.

Comparison of the immunogenicity of intramuscular versus subcutaneous administration of trivalent inactivated influenza vaccine in individuals with neuromuscular diseases.

Golekoh MC, Hu S, Norman AM, Horn PS, Brady RC, Wong BL.

J Child Neurol. 2013 May;28(5):596-601. doi: 10.1177/0883073813480243. Epub 2013 Mar 12.

PMID:
23481448
[PubMed - indexed for MEDLINE]
12.

Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes.

Leroux-Roels G, Maes C, Clement F, van Engelenburg F, van den Dobbelsteen M, Adler M, Amacker M, Lopalco L, Bomsel M, Chalifour A, Fleury S.

PLoS One. 2013;8(2):e55438. doi: 10.1371/journal.pone.0055438. Epub 2013 Feb 20.

PMID:
23437055
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice.

Magnusson SE, Reimer JM, Karlsson KH, Lilja L, Bengtsson KL, Stertman L.

Vaccine. 2013 Mar 25;31(13):1725-33. doi: 10.1016/j.vaccine.2013.01.039. Epub 2013 Feb 4.

PMID:
23384754
[PubMed - indexed for MEDLINE]
14.

Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.

Wongsaroj P, Udomchaisakul P, Tepsumethanon S, Khawplod P, Tantawichien T.

Vaccine. 2013 Mar 25;31(13):1748-51. doi: 10.1016/j.vaccine.2013.01.035. Epub 2013 Jan 29.

PMID:
23370149
[PubMed - indexed for MEDLINE]
15.

Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01.

Otsyula N, Angov E, Bergmann-Leitner E, Koech M, Khan F, Bennett J, Otieno L, Cummings J, Andagalu B, Tosh D, Waitumbi J, Richie N, Shi M, Miller L, Otieno W, Otieno GA, Ware L, House B, Godeaux O, Dubois MC, Ogutu B, Ballou WR, Soisson L, Diggs C, Cohen J, Polhemus M, Heppner DG Jr, Ockenhouse CF, Spring MD.

Malar J. 2013 Jan 23;12(1):29. doi: 10.1186/1475-2875-12-29.

PMID:
23342996
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Vaccination site and risk of local reactions in children 1 through 6 years of age.

Jackson LA, Peterson D, Nelson JC, Marcy SM, Naleway AL, Nordin JD, Donahue JG, Hambidge SJ, Balsbaugh C, Baxter R, Marsh T, Madziwa L, Weintraub E.

Pediatrics. 2013 Feb;131(2):283-9. doi: 10.1542/peds.2012-2617. Epub 2013 Jan 14.

PMID:
23319538
[PubMed - indexed for MEDLINE]
Free Article
17.

[Evaluation of safety of prophylactic use of immunoglobulins against viral hemorrhagic fevers from horse blood sera].

Khmelev AL, Borisevich IV, Chernikova NK, Makhlaĭ AA, Mikhaĭlov VV, Iakovlev AK, Podkuĭko VN, Krasnianskiĭ VP, Borisevich SV, Bondarev VP.

Zh Mikrobiol Epidemiol Immunobiol. 2012 Nov-Dec;(6):103-6. Russian.

PMID:
23297643
[PubMed - indexed for MEDLINE]
18.

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.

Meyer J, Harris SA, Satti I, Poulton ID, Poyntz HC, Tanner R, Rowland R, Griffiths KL, Fletcher HA, McShane H.

Vaccine. 2013 Feb 4;31(7):1026-33. doi: 10.1016/j.vaccine.2012.12.042. Epub 2012 Dec 21.

PMID:
23266342
[PubMed - indexed for MEDLINE]
19.

Biosafety of the plasmid pcDNA3-1E of Eimeria acervulina in chicken.

Zhao Y, Bao Y, Zhang L, Chang L, Jiang L, Liu Y, Zhang L, Qin J.

Exp Parasitol. 2013 Mar;133(3):231-6. doi: 10.1016/j.exppara.2012.11.026. Epub 2012 Dec 13.

PMID:
23247194
[PubMed - indexed for MEDLINE]
20.

Intramuscular inoculation of mice with the live-attenuated recombinant rabies virus TriGAS results in a transient infection of the draining lymph nodes and a robust, long-lasting protective immune response against rabies.

Schutsky K, Curtis D, Bongiorno EK, Barkhouse DA, Kean RB, Dietzschold B, Hooper DC, Faber M.

J Virol. 2013 Feb;87(3):1834-41. doi: 10.1128/JVI.02589-12. Epub 2012 Nov 28.

PMID:
23192867
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk